HEADER TRANSFERASE 24-JUL-15 5AAE TITLE AURORA A KINASE BOUND TO AN IMIDAZOPYRIDINE INHIBITOR (14D) COMPND MOL_ID: 1; COMPND 2 MOLECULE: AURORA KINASE A; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN, UNP RESIDUES 112-403; COMPND 5 SYNONYM: AURORA 2, AURORA/IPL1-RELATED KINASE 1, ARK-1, AURORA- COMPND 6 RELATED KINASE 1, HARK1, BREAST TUMOR-AMPLIFIED KINASE, SERINE/ COMPND 7 THREONINE-PROTEIN KINASE 15, SERINE/THREONINE-PROTEIN KINASE 6, COMPND 8 SERINE/ THREONINE-PROTEIN KINASE AURORA-A, AURORA A; COMPND 9 EC: 2.7.11.1; COMPND 10 ENGINEERED: YES; COMPND 11 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSFERASE, AURORA-A, IMIDAZOPYRIDINE, AURORA KINASE, INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR P.J.MCINTYRE,R.BAYLISS REVDAT 3 10-JAN-24 5AAE 1 REMARK REVDAT 2 23-SEP-15 5AAE 1 JRNL REVDAT 1 02-SEP-15 5AAE 0 JRNL AUTH V.BAVETSIAS,Y.PEREZ-FUERTES,P.J.MCINTYRE,B.ATRASH, JRNL AUTH 2 M.KOSMOPOULOU,L.O'FEE,R.BURKE,C.SUN,A.FAISAL,K.BUSH,S.AVERY, JRNL AUTH 3 A.HENLEY,F.I.RAYNAUD,S.LINARDOPOULOS,R.BAYLISS,J.BLAGG JRNL TITL 7-(PYRAZOL-4-YL)-3H-IMIDAZO[4,5-B]PYRIDINE-BASED DERIVATIVES JRNL TITL 2 FOR KINASE INHIBITION: CO-CRYSTALLISATION STUDIES WITH JRNL TITL 3 AURORA-A REVEAL DISTINCT DIFFERENCES IN THE ORIENTATION OF JRNL TITL 4 THE PYRAZOLE N1-SUBSTITUENT. JRNL REF BIOORG.MED.CHEM.LETT. V. 25 4203 2015 JRNL REFN ISSN 0960-894X JRNL PMID 26296477 JRNL DOI 10.1016/J.BMCL.2015.08.003 REMARK 2 REMARK 2 RESOLUTION. 3.11 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.11 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 54.13 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 6450 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.241 REMARK 3 R VALUE (WORKING SET) : 0.238 REMARK 3 FREE R VALUE : 0.291 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 310 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 54.1329 - 3.9184 1.00 3180 141 0.2238 0.2669 REMARK 3 2 3.9184 - 3.1102 1.00 2960 169 0.2949 0.3778 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.520 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 31.960 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 118.3 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 2063 REMARK 3 ANGLE : 0.807 2805 REMARK 3 CHIRALITY : 0.031 307 REMARK 3 PLANARITY : 0.003 356 REMARK 3 DIHEDRAL : 17.017 745 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5AAE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 24-JUL-15. REMARK 100 THE DEPOSITION ID IS D_1290064368. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-APR-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.9 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.976 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XIA2 REMARK 200 DATA SCALING SOFTWARE : XIA2 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 6482 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.110 REMARK 200 RESOLUTION RANGE LOW (A) : 54.120 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.600 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 8.700 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 23.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.11 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.19 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : 9.50 REMARK 200 R MERGE FOR SHELL (I) : 0.81000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 4BYI REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.68 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.49 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M TRIS PH 8.9 0.2 M LITHIUM REMARK 280 SULFATE 30 % PEG 4000 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 7555 Y,X,-Z+1/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+2/3 REMARK 290 10555 -Y,-X,-Z+5/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 55.94667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 111.89333 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 83.92000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 139.86667 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 27.97333 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 55.94667 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 111.89333 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 139.86667 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 83.92000 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 27.97333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 119 REMARK 465 ALA A 120 REMARK 465 MET A 121 REMARK 465 GLU A 122 REMARK 465 SER A 123 REMARK 465 LYS A 124 REMARK 465 LYS A 125 REMARK 465 HIS A 280 REMARK 465 ALA A 281 REMARK 465 PRO A 282 REMARK 465 SER A 283 REMARK 465 SER A 284 REMARK 465 ARG A 285 REMARK 465 ARG A 286 REMARK 465 THR A 287 REMARK 465 THR A 288 REMARK 465 LEU A 289 REMARK 465 ALA A 290 REMARK 465 LYS A 389 REMARK 465 PRO A 390 REMARK 465 SER A 391 REMARK 465 ASN A 392 REMARK 465 ALA A 393 REMARK 465 GLN A 394 REMARK 465 ASN A 395 REMARK 465 LYS A 396 REMARK 465 GLU A 397 REMARK 465 SER A 398 REMARK 465 ALA A 399 REMARK 465 SER A 400 REMARK 465 LYS A 401 REMARK 465 GLN A 402 REMARK 465 SER A 403 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 126 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 127 CG CD OE1 NE2 REMARK 470 LYS A 141 CG CD CE NZ REMARK 470 LYS A 143 CG CD CE NZ REMARK 470 PHE A 165 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 166 CG CD CE NZ REMARK 470 GLN A 168 CG CD OE1 NE2 REMARK 470 LEU A 169 CG CD1 CD2 REMARK 470 GLU A 170 CG CD OE1 OE2 REMARK 470 LYS A 171 CG CD CE NZ REMARK 470 GLU A 175 CG CD OE1 OE2 REMARK 470 HIS A 176 CG ND1 CD2 CE1 NE2 REMARK 470 GLN A 177 CG CD OE1 NE2 REMARK 470 ARG A 179 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 180 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 181 CG CD OE1 OE2 REMARK 470 GLU A 183 CG CD OE1 OE2 REMARK 470 ARG A 189 NE CZ NH1 NH2 REMARK 470 TYR A 199 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ARG A 375 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 131 36.26 -79.53 REMARK 500 HIS A 176 -70.91 -36.22 REMARK 500 ASP A 202 -148.63 -100.64 REMARK 500 SER A 226 -48.84 66.52 REMARK 500 ARG A 255 -65.55 60.10 REMARK 500 ALA A 273 -104.86 -95.89 REMARK 500 TRP A 277 60.97 -107.00 REMARK 500 ALA A 331 -169.40 -127.42 REMARK 500 VAL A 344 71.22 51.96 REMARK 500 LEU A 364 67.06 -100.78 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 7HD A 1389 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5AAD RELATED DB: PDB REMARK 900 AURORA A KINASE BOUND TO AN IMIDAZOPYRIDINE INHIBITOR ( 7A) REMARK 900 RELATED ID: 5AAF RELATED DB: PDB REMARK 900 AURORA A KINASE BOUND TO AN IMIDAZOPYRIDINE INHIBITOR ( 14A) REMARK 900 RELATED ID: 5AAG RELATED DB: PDB REMARK 900 AURORA A KINASE BOUND TO AN IMIDAZOPYRIDINE INHIBITOR ( 14B) DBREF 5AAE A 122 403 UNP O14965 AURKA_HUMAN 122 403 SEQADV 5AAE GLY A 119 UNP O14965 EXPRESSION TAG SEQADV 5AAE ALA A 120 UNP O14965 EXPRESSION TAG SEQADV 5AAE MET A 121 UNP O14965 EXPRESSION TAG SEQADV 5AAE ALA A 290 UNP O14965 CYS 290 ENGINEERED MUTATION SEQADV 5AAE ALA A 393 UNP O14965 CYS 393 ENGINEERED MUTATION SEQRES 1 A 285 GLY ALA MET GLU SER LYS LYS ARG GLN TRP ALA LEU GLU SEQRES 2 A 285 ASP PHE GLU ILE GLY ARG PRO LEU GLY LYS GLY LYS PHE SEQRES 3 A 285 GLY ASN VAL TYR LEU ALA ARG GLU LYS GLN SER LYS PHE SEQRES 4 A 285 ILE LEU ALA LEU LYS VAL LEU PHE LYS ALA GLN LEU GLU SEQRES 5 A 285 LYS ALA GLY VAL GLU HIS GLN LEU ARG ARG GLU VAL GLU SEQRES 6 A 285 ILE GLN SER HIS LEU ARG HIS PRO ASN ILE LEU ARG LEU SEQRES 7 A 285 TYR GLY TYR PHE HIS ASP ALA THR ARG VAL TYR LEU ILE SEQRES 8 A 285 LEU GLU TYR ALA PRO LEU GLY THR VAL TYR ARG GLU LEU SEQRES 9 A 285 GLN LYS LEU SER LYS PHE ASP GLU GLN ARG THR ALA THR SEQRES 10 A 285 TYR ILE THR GLU LEU ALA ASN ALA LEU SER TYR CYS HIS SEQRES 11 A 285 SER LYS ARG VAL ILE HIS ARG ASP ILE LYS PRO GLU ASN SEQRES 12 A 285 LEU LEU LEU GLY SER ALA GLY GLU LEU LYS ILE ALA ASP SEQRES 13 A 285 PHE GLY TRP SER VAL HIS ALA PRO SER SER ARG ARG THR SEQRES 14 A 285 THR LEU ALA GLY THR LEU ASP TYR LEU PRO PRO GLU MET SEQRES 15 A 285 ILE GLU GLY ARG MET HIS ASP GLU LYS VAL ASP LEU TRP SEQRES 16 A 285 SER LEU GLY VAL LEU CYS TYR GLU PHE LEU VAL GLY LYS SEQRES 17 A 285 PRO PRO PHE GLU ALA ASN THR TYR GLN GLU THR TYR LYS SEQRES 18 A 285 ARG ILE SER ARG VAL GLU PHE THR PHE PRO ASP PHE VAL SEQRES 19 A 285 THR GLU GLY ALA ARG ASP LEU ILE SER ARG LEU LEU LYS SEQRES 20 A 285 HIS ASN PRO SER GLN ARG PRO MET LEU ARG GLU VAL LEU SEQRES 21 A 285 GLU HIS PRO TRP ILE THR ALA ASN SER SER LYS PRO SER SEQRES 22 A 285 ASN ALA GLN ASN LYS GLU SER ALA SER LYS GLN SER HET 7HD A1389 29 HETNAM 7HD 3-((4-(6-CHLORO-2-(1,3-DIMETHYL-1H-PYRAZOL-4-YL)-3H- HETNAM 2 7HD IMIDAZO[4,5-B]PYRIDIN-7-YL)-1H-PYRAZOL-1-YL)METHYL)-5- HETNAM 3 7HD METHYLISOXAZOLE FORMUL 2 7HD C19 H17 CL N8 O HELIX 1 1 ALA A 129 GLU A 131 5 3 HELIX 2 2 LYS A 166 LYS A 171 1 6 HELIX 3 3 VAL A 174 HIS A 187 1 14 HELIX 4 4 VAL A 218 SER A 226 1 9 HELIX 5 5 ASP A 229 SER A 249 1 21 HELIX 6 6 LYS A 258 GLU A 260 5 3 HELIX 7 7 PRO A 297 GLY A 303 1 7 HELIX 8 8 LYS A 309 GLY A 325 1 17 HELIX 9 9 THR A 333 VAL A 344 1 12 HELIX 10 10 THR A 353 LEU A 364 1 12 HELIX 11 11 ASN A 367 ARG A 371 5 5 HELIX 12 12 MET A 373 GLU A 379 1 7 HELIX 13 13 HIS A 380 SER A 387 1 8 SHEET 1 AA 5 PHE A 133 GLY A 140 0 SHEET 2 AA 5 GLY A 145 GLU A 152 -1 O VAL A 147 N LEU A 139 SHEET 3 AA 5 ILE A 158 PHE A 165 -1 O LEU A 159 N ALA A 150 SHEET 4 AA 5 ARG A 205 GLU A 211 -1 O VAL A 206 N LEU A 164 SHEET 5 AA 5 LEU A 196 HIS A 201 -1 N TYR A 197 O ILE A 209 SHEET 1 AB 3 GLY A 216 THR A 217 0 SHEET 2 AB 3 LEU A 262 LEU A 264 -1 N LEU A 264 O GLY A 216 SHEET 3 AB 3 LEU A 270 ILE A 272 -1 O LYS A 271 N LEU A 263 SITE 1 AC1 14 ARG A 137 LEU A 139 GLY A 140 GLY A 142 SITE 2 AC1 14 GLY A 145 VAL A 147 ALA A 160 LYS A 162 SITE 3 AC1 14 GLU A 211 ALA A 213 PRO A 214 GLY A 216 SITE 4 AC1 14 LEU A 263 ARG A 343 CRYST1 81.780 81.780 167.840 90.00 90.00 120.00 P 61 2 2 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012228 0.007060 0.000000 0.00000 SCALE2 0.000000 0.014120 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005958 0.00000